These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 220840)

  • 1. Lymphocyte blast transformation response of seropositive and seronegative subjects to herpes simplex, rubella, mumps and measles virus antigens.
    Ilonen J
    Acta Pathol Microbiol Scand C; 1979 Apr; 87C(2):151-7. PubMed ID: 220840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of the immune status against the viruses of measles, mumps, rubella, and hepatitis B in a cohort of students from the province of Como].
    Fraizzoli G; Sesana BM
    Ann Ig; 1989; 1(5):1163-71. PubMed ID: 2483899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunity to and immunization against measles, rubella and mumps in patients after autologous bone marrow transplantation.
    Pauksen K; Duraj V; Ljungman P; Sjölin J; Oberg G; Lönnerholm G; Fridell E; Smedmyr B; Simonsson B
    Bone Marrow Transplant; 1992 Jun; 9(6):427-32. PubMed ID: 1628126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human leukocyte antigen haplotypes in the genetic control of immune response to measles-mumps-rubella vaccine.
    Ovsyannikova IG; Pankratz VS; Vierkant RA; Jacobson RM; Poland GA
    J Infect Dis; 2006 Mar; 193(5):655-63. PubMed ID: 16453260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocyte blast transformation responses and viral antibodies in relation to HLA antigens in multiple sclerosis.
    Ilonen J; Reunanen M; Salmi A; Tiilikainen A
    J Neurol Sci; 1981 Jan; 49(1):117-33. PubMed ID: 6259296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measles-mumps-rubella and varicella vaccine responses in extremely preterm infants.
    D'Angio CT; Boohene PA; Mowrer A; Audet S; Menegus MA; Schmid DS; Beeler JA
    Pediatrics; 2007 Mar; 119(3):e574-9. PubMed ID: 17332177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Use of the IgM fraction from patients' sera in general virus serology for diagnostic purposes].
    Wolff MH; Marklein G; Schneweis KE; Stifter G
    Zentralbl Bakteriol Orig A; 1974; 227(1-4):392-400. PubMed ID: 4154618
    [No Abstract]   [Full Text] [Related]  

  • 8. Cellular immunity to mumps virus in young adults 21 years after measles-mumps-rubella vaccination.
    Jokinen S; Osterlund P; Julkunen I; Davidkin I
    J Infect Dis; 2007 Sep; 196(6):861-7. PubMed ID: 17703416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune functions in healthy blood donors with HLA-DW2 and -DW3 antigens.
    Ilonen J; Salonen R; Hyypiä T; Lankinen K; Karttunen R; Salmi A
    Immunobiology; 1986 Jul; 171(4-5):388-99. PubMed ID: 3488954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Humoral and cellular immunity to selected viral antigens in children from the Bełchatów Industrial Region].
    Stempień R; Słowińska I; Wardecka J; Deroń Z; Imbs D; Jankowski M; Jarzabek Z; Kańtoch M
    Med Dosw Mikrobiol; 1983; 35(3-4):259-68. PubMed ID: 6676608
    [No Abstract]   [Full Text] [Related]  

  • 11. [Morbidity, vaccine coverage and immunity against measles, mumps and rubella in a Gallician population from 2 to 5 years old].
    Vázquez Fernández E; López Rois F; Vázquez Carrete JA; Gómez Tato B; Alvarez Ares M
    An Esp Pediatr; 1987 Jul; 27(1):27-31. PubMed ID: 3662251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K; Nicoara C; Germann D; Matter L
    Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of mumps and immunity to measles, mumps and rubella among US military recruits, 2000-2004.
    Eick AA; Hu Z; Wang Z; Nevin RL
    Vaccine; 2008 Jan; 26(4):494-501. PubMed ID: 18155326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The response of human lymphocyte subpopulations to measles, mumps, and vaccinia viral antigens.
    McFarland HF; Pedone CA; Mingioli ES; McFarlin DE
    J Immunol; 1980 Jul; 125(1):221-5. PubMed ID: 6966650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic activity against rubella-infected cells in the supernatants of human lymphocyte cultures stimulated by rubella virus.
    Kanra GY; Vesikari T
    Clin Exp Immunol; 1975 Jan; 19(1):17-32. PubMed ID: 1204239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: loss of specific antibodies against attenuated vaccine strains and natural viral infection.
    Bekker V; Scherpbier H; Pajkrt D; Jurriaans S; Zaaijer H; Kuijpers TW
    Pediatrics; 2006 Aug; 118(2):e315-22. PubMed ID: 16847077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of vaccination with measles-mumps-rubella vaccine at 9, 12, and 15 months of age.
    Redd SC; King GE; Heath JL; Forghani B; Bellini WJ; Markowitz LE
    J Infect Dis; 2004 May; 189 Suppl 1():S116-22. PubMed ID: 15106100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years.
    Vesikari T; Baer M; Willems P
    Pediatr Infect Dis J; 2007 Feb; 26(2):153-8. PubMed ID: 17259879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measles, mumps, rubella antibody surveillance: pilot study in Grampian, Scotland.
    Narayan KM; Moffat MA
    Health Bull (Edinb); 1992 Jan; 50(1):47-53. PubMed ID: 1612895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte blast transformation responses in measles infection.
    Ilonen J; Lanning M; Herva E; Salmi A
    Scand J Immunol; 1980; 12(5):383-91. PubMed ID: 7466326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.